Antibiotic therapy in pregnancy and lactation

Journal of Chemotherapy

Volumn 17, Issue 2, 2005, Pages 123-130

  Reali, A ^a   Ximenes, A ^a   Cuzzolin, L ^b   Fanos, V ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Antibiotics; Drug administration during lactation; Drug administration during pregnancy; Lactation; Pregnancy

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPICILLIN; AZITHROMYCIN; AZTREONAM; CARBAPENEM DERIVATIVE; CEFACLOR; CEFALEXIN; CEFALOTIN; CEFRADINE; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DICLOXACILLIN; DOXYCYCLINE; ERYTHROMYCIN; ETHAMBUTOL; FLUCONAZOLE; GENTAMICIN; IMIDAZOLE; ISONIAZID; KANAMYCIN; KETOCONAZOLE; MACROLIDE; MEROPENEM; METRONIDAZOLE; MINOCYCLINE; MONOBACTAM DERIVATIVE; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; NYSTATIN; OFLOXACIN; PENICILLIN DERIVATIVE; PENICILLIN G; PENICILLIN V; PIPERACILLIN; PYRIMETHAMINE; QUINOLONE DERIVATIVE; RIFAMPICIN; SPIRAMYCIN; STREPTOMYCIN; SULFADIAZINE; SULFADOXINE; SULFAMETHOXAZOLE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; TRIMETHOPRIM DERIVATIVE; TUBERCULOSTATIC AGENT; VANCOMYCIN;

ANAEROBIC INFECTION; ANTIBIOTIC THERAPY; ARTHROPATHY; BACTERIAL INFECTION; BLOOD PLACENTA BARRIER; BONE GROWTH; BREAST FEEDING; BREAST MILK; CANDIDIASIS; CARCINOGENICITY; CARDIOVASCULAR DISEASE; CATARACT; CHORIOAMNIONITIS; CLEFT PALATE; COLOSTRUM; DEPRESSION; DIARRHEA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG HYPERSENSITIVITY; DRUG METABOLISM; ENDOMETRITIS; GASTROINTESTINAL SYMPTOM; GENITAL TRACT INFECTION; GROWTH RETARDATION; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; HYPOPLASIA; INTESTINE FLORA; INTRAUTERINE INFECTION; KERNICTERUS; KIDNEY DISEASE; LACTATION; LIVER TOXICITY; MENINGOCOCCOSIS; MUTAGENICITY; MYCOSIS; NEPHROTOXICITY; NEWBORN JAUNDICE; NONHUMAN; OTOTOXICITY; PELVIC INFLAMMATORY DISEASE; PHARYNGITIS; PIGMENT DISORDER; PLASMA PROTEIN BINDING; PREGNANCY; PRENATAL DRUG EXPOSURE; PUERPERAL INFECTION; PYLORUS STENOSIS; RASH; REVIEW; SEPSIS; SIDE EFFECT; STREPTOCOCCUS INFECTION; TERATOGENICITY; TOXOPLASMOSIS; TUBERCULOSIS; URINARY TRACT INFECTION; VAGINITIS; VESTIBULOCOCHLEAR NERVE DISEASE;

EID: 19644366070     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.2.123     Document Type: Review

References (43)

1. Stika CS, Frederiksen MC. Drug Therapy in Pregnant and Nursing Women. In: Atkinson AJ, Daniels CE, Dedrick RL, Grudzinskas CV & Markey SP eds. Principles of Clinical Pharmacology. San Diego: Academic Press.2001: 277-291.
2. Bossens M. Antibiotics and pregnancy. Rev Med Brux 2001; 22: 260-263.
3. Chow AW, Jewesson PJ. Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect Dis 1985;7:287-313.
4. Frederiksen MC. Physiologic changes in pregnancy and their effect on drug disposition. Semin Perinatol 2001;25: 120-123.
5. Rubin PC. Drugs in Special Patient Groups: Pregnancy and Nursing. In: Melmon KL, Morrelli HF, Hoffman BB & Nierenberg DW, eds. Melmon and Morelli's Clinical Pharmacology: Basic Principles in Therapeutics. 3rd ed. New York: McGraw-Hill.1992: 805-825.
6. Morgan DJ. Drug disposition in mother and foetus. Clin Exp Pharmacol Physiol 1997: 24: 869-873.
7. Koren G. Special Aspects of Perinatal and Pediatric Pharmacology. In: Katzung BG, eds. Basic & Clinical Pharmacology 9th ed. New York: Lange Medical Books/McGraw Hill.2004: 995-1006.
8. Wislicki L. Factors affecting the mode of drug action in pregnancy. In: Kuemmerle HP, eds. Clinical Pharmacology in Pregnancy: Fundamentals and Rational Pharmacotherapy. New York: Thieme-Strattons 1984: 124-128.
9. Brendel K, Duhamel RC. Drug Metabolism in the fetus. In: Kemmerle HP, eds. Clinical Pharmacology in Pregnancy: Fundamentals and Rational Pharmacotherapy. New York: Thieme-Strattons 1984: 87-100.
10. Niebyl JR. Antibiotics and other anti-infective agents in pregnancy and lactation. Am J Perinatol 2003; 20: 405-414.
11. Einarson A., Shuhaiber S, Koren G. Effects of antibacterials on the unborn child: what is known and how should this influence prescribing. Paediatr Drugs 2001; 3: 803-816.
12. Marks JM, Spatz DL. Medications and Lactation: what PNPs need to know. J Pediatr Health Care 2003; 17:311-317.
13. Chung AM, Reed MD, Blumer JL. Antibiotics and breast-feeding: a critical review of the literature. Paediatr Drugs 2002;4:817-837.
14. Banta-Wright SA. Minimizing infant exposure to and risks from medications while breastfeeding. J Perinat Neonat Nursing 1997; 11: 71-84.
15. Hale TW, eds. Medications and mothers' milk. 10th ed. Amarillo, TX: Pharmasoft 2000.
16. Gardiner S, Begg E. Drug Safety in Lactation. Prescriber Update Articles, May 2001;21:10-23.
17. Pergament E, Schechtman A, Blum K. Antibiotics and pregnancy. Risk Newsletter vol 3#6 1995. www.fetal-exposure.org/ANTIBIOT.html-24/04/2004.
18. Briggs GG, Freeman RK, Jaffe SJ, eds. Drugs in pregnancy and lactation. Philadelphia: Lippincott Williams & Wilkins 2002: 284.
19. Mercer BM, Goldenberg RL, Das AF et al. What we have learned regarding antibiotic therapy for the reduction of infant morbidity after preterm premature rupture of the membranes. Semin Perinatol 2003; 27: 217-230.
20. Jepsen P, Skriver MV, Floyd A, Lipworth L, Schonheyder HC, Sorensen HT. A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark. Br J Clin Pharmacol 2003; 55: 216-221.
21. World Healt Organization Breastfeeding and maternal medication Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs 2002.
22. American Academy of Pediatrics. Committee on Drugs. The transfer of drugs and other chemicals into human milk. Pediatrics 2001; 108: 776-789.
23. Czeizel AE, Rockenbauer M., Sorensen HT, Olsen J. Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study. Eur J Obstet Gynecol Reprod Biol 2001; 97: 188-192.
24. Carter M, Wilson F. Antibiotics and congenital malformations. Lancet 1963;1: 1267-1268.
25. Czeizel AE, Rockenbauer M., Sorensen HT, Olsen J. Use of cephalosporins during pregnancy and in the presence of congenital abnormalities: a population-based case-control study. Am J Obstet Gynecol. 2001; 184: 1289-1296.
26. Bourget P, Quinquis-Desmaris V, Fernandez H. Ceftriaxone distribution and protein binding between maternal blood and milk postpartum. Ann Pharmacother 1993; 27: 294-297.
27. Kafetzis DA, Siafas CA, Georgakopoulos PA, Papadatos CJ. Passage of cephalosporins and amoxicillin into the breast milk. Acta Paediatr Scand 1981;70:285-288.
28. Jorgensen NP, Walstad RA, Moine K. The concentrations of ceftazidime and thiopental in maternal plasma, placental tissue and amniotic fluid In early pregnancy. Acta Obstet Gynecol Scand 1987; 66: 29-33.
29. Blanco JD, Jorgensen JH, Castaneda YS, Crawford SA. Ceftazidime levels in human breast milk. Antimicrob Agents Chemother 1983; 23: 479-480.
30. Hirabayashi K, Okada E. Pharmacokinetic and clinical studies of imipenem/cilastatin sodium in the perinatal period. Jpn J Antibiot 1988; 11; 1797-1804.
31. Cho N, Fukunaga K, Kunli K, Kobayashi I., Tezuka K. Studies on imipenem/cilastatin in the perinatal period. Jpn J Antibiot 1988; 11: 1758-1773.
32. Jones HC. Intrauterine ototoxicity. A case report and review of literature. J Natl Med Assoc 1973;65: 201-203.
33. Celiloglu M, Celiker S, Guven H.Tuncok Y, Demir N, Erten O. Gentamicin excretion and uptake from breast milk by nursing infants. Obstet Gynecol 1994; 84:263-265.
34. McCormack WM, George H, Donner A et al. Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents Chemother 1977; 12: 630-635.
35. Stang H. Pyloric stenosis associated with erythromycin ingested through breastmilk. Min Med. 1986; 69:669-670.
36. Goisis M, Cavalli P. Variations of the organoleptic properties of human milk under treatment with antibiotics. In: Onnis A & Grella P,eds. The Biochemical Effects of Drugs in Pregnancy. Chichester: Ellis Horwood Ltd 1984: 340-341.
37. Einarson A, Phillips E, D'Alimonte D et al. A prospective controlled multicentre study of clarithromycin in pregnancy. Am J Pennatol 1998; 15:523-525.
38. Giamarellou H, Kolokithas E, Petrikkos G, Gazis J, Aravantinos D, Sfikakis P. Pharmacokinetics of three newer quinolones in pregnant and lactating women. Am J Med 1989, 87: 49S - 51S.
39. Bar-Oz B, Bulkowstein M, Benyamini L et al. Use of antibiotic and analgesic drugs during lactation. Drug Saf 2003; 26: 925-935.
40. American Thoracic Society, Centre for Disease Control and Prevention and Infectious Diseases Society of America. Treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-662.
41. Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 2001; 24: 553-565.
42. King CT, Rogers PD, Cleary JD, Chapman SW. Antifungal therapy during pregnancy. Clin Infect Dis 1998; 27: 1151-1160.
43. Sobel JD. Use of antifungal drugs in pregnancy: a focus on safety. Drug Safety 2000; 23: 77-85.